Locus-Specific DNA Methylation Editing in Melanoma Cell Lines Using a CRISPR-Based System

• Published in: Cancers Vol. 13; no. 21; p. 5433
• Main Authors: Smith, Jim, Banerjee, Rakesh, Waly, Reema, Urbano, Arthur, Gimenez, Gregory, Day, Robert, Eccles, Michael R., Weeks, Robert J., Chatterjee, Aniruddha
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 29-10-2021; MDPI
• Subjects: Cloning; CRISPR; Demethylation; Deoxyribonucleic acid; Design; DNA; DNA methylation; Editing; Epigenetics; Etiology; Gene expression; Gene loci; Genomes; Melanoma; Metastases; Plasmids; Proteins; Protocol; Transcription; United Kingdom > UK; England; United States > US
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers13215433

DNA methylation is a key epigenetic modification implicated in the pathogenesis of numerous human diseases, including cancer development and metastasis. Gene promoter methylation changes are widely associated with transcriptional deregulation and disease progression. The advent of CRISPR-based technologies has provided a powerful toolkit for locus-specific manipulation of the epigenome. Here, we describe a comprehensive global workflow for the design and application of a dCas9-SunTag-based tool for editing the DNA methylation locus in human melanoma cells alongside protocols for downstream techniques used to evaluate subsequent methylation and gene expression changes in methylation-edited cells. Using transient system delivery, we demonstrate both highly efficacious methylation and demethylation of the EBF3 promoter, which is a putative epigenetic driver of melanoma metastasis, achieving up to a 304.00% gain of methylation and 99.99% relative demethylation, respectively. Furthermore, we employ a novel, targeted screening approach to confirm the minimal off-target activity and high on-target specificity of our designed guide RNA within our target locus.